Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Response Biomed Corp RPBIF

Healthcare Diagnostics & Research
"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."

GREY:RPBIF - Post Discussion

Response Biomed Corp > Good News
View:
Post by dimar66 on Jan 03, 2013 1:59pm

Good News

Newly formed US subsidiary, good news, we are serious about devloping the US market.

The distribution agreement was entered into between Response Biomedical's newly formed, wholly owned U.S. subsidiary Response Point of Care Inc. and LABSCO for an initial term of three years and is renewable annually thereafter upon mutual agreement. LABSCO will initially market Response's cardiovascular POC test panels on the RAMP(R) Reader in all settings and on the RAMP(R) 200 reader in laboratory settings. Response will continue to market the cardiovascular POC test panel on both the RAMP(R) 200 reader and RAMP(R) Reader outside the US, and the RAMP(R) Flu A+B Assay and RAMP(R) RSV Assay on the RAMP(R) 200 reader globally where approved for sale by relevant regulatory authorities.

Be the first to comment on this post
Response Biomed Corp